• 1. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
• 2. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 3. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 4. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 5. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Methoxybenzoic acids and derivatives

Recent Advances in the Study of 2-Hydroxy-3-methoxy-5-methylbenzoic Acid (CAS: 4386-42-9): A Comprehensive Research Brief

2-Hydroxy-3-methoxy-5-methylbenzoic Acid (CAS: 4386-42-9) is a phenolic acid derivative that has garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential therapeutic applications. Recent studies have explored its structural properties, biological activities, and synthetic pathways, highlighting its relevance in drug discovery and development. This research brief synthesizes the latest findings on this compound, providing a detailed overview of its current applications and future prospects.

The compound's unique chemical structure, characterized by a hydroxy group at the 2-position, a methoxy group at the 3-position, and a methyl group at the 5-position of the benzoic acid scaffold, contributes to its diverse biological activities. Recent investigations have focused on its antioxidant, anti-inflammatory, and antimicrobial properties, which make it a promising candidate for the development of novel therapeutics. Advanced spectroscopic techniques, including NMR and mass spectrometry, have been employed to elucidate its molecular interactions and stability under various conditions.

In a groundbreaking study published in the Journal of Medicinal Chemistry, researchers demonstrated the compound's efficacy in inhibiting key enzymes involved in inflammatory pathways. The study utilized in vitro assays and molecular docking simulations to reveal its binding affinity for cyclooxygenase-2 (COX-2), suggesting potential applications in the treatment of chronic inflammatory diseases. These findings are supported by complementary research in animal models, where the compound exhibited significant reduction in inflammation markers without adverse effects.

Another area of active research involves the synthetic optimization of 2-Hydroxy-3-methoxy-5-methylbenzoic Acid. A recent paper in Organic & Biomolecular Chemistry detailed a novel green chemistry approach for its synthesis, employing catalytic methods that reduce environmental impact while maintaining high yield and purity. This advancement addresses the growing demand for sustainable pharmaceutical production and aligns with global initiatives for greener chemical processes.

The compound's potential in oncology has also been explored. Preliminary studies indicate that it may act as a modulator of cellular apoptosis pathways, particularly in certain cancer cell lines. Researchers are investigating its synergistic effects with existing chemotherapeutic agents, with the aim of enhancing treatment efficacy while minimizing side effects. These studies are still in early stages, but the results are encouraging and warrant further investigation.

In conclusion, 2-Hydroxy-3-methoxy-5-methylbenzoic Acid (CAS: 4386-42-9) represents a versatile compound with broad applications in pharmaceutical research. Its multifaceted biological activities, coupled with advancements in synthetic methodologies, position it as a valuable asset in the development of next-generation therapeutics. Future research should focus on clinical translation, pharmacokinetic profiling, and large-scale production to fully realize its therapeutic potential.

• 490-64-2(2,4,5-Trimethoxybenzoic acid)
• 877-22-5(o-Vanillic Acid)
• 3507-08-2(5-Carboxyvanillin)
• 1521-38-6(2,3-Dimethoxybenzoic acid)
• 100111-46-4(Benzoic acid,2,4,5-trihydroxy-3-methoxy-)
• 118303-91-6(Benzoic acid,3,6-dihydroxy-2-methoxy-)
• 2169-28-0(3-hydroxy-2-methoxybenzoic acid)
• 573-11-5(2,3,4-Trimethoxybenzoic acid)
• 2134-91-0(5-Carboxyvanillic Acid)
• 100111-45-3(Benzoic acid,2,3,4-trihydroxy-5-methoxy-)